SECTOR
Bacil Pharma proposes to incorporate wholly-owned subsidiary
Jun-18-2026

Bacil Pharma has proposed to incorporate a wholly-owned subsidiary company in the name and style of ‘Bacil Research & Development’, subject to approval of the Registrar of Companies and other applicable statutory authorities.

The proposed company shall be incorporated as a private limited company. The incorporation is proposed with the objective of undertaking research and development activities and such other allied activities as may be permitted under applicable laws.

Bacil Pharma is primarily engaged in healthcare solutions focusing on the development, manufacturing, and distribution of pharmaceutical formulations including tablets, capsules, ointments, injectables, and specialty products. All operations comply with the relevant regulatory and quality standards.


  RELATED NEWS >>